Leadership Announcement Dr. Natalia Gonzalez Caldito Named Chief of Staff at Hawaiʻi Pacific Neuroscience A milestone promotion recognising exceptional leadership, clinical innovation, and a pioneering dual-fellowship programme that has transformed specialised neurological care across the Hawaiian Islands. Natalia Gonzalez Caldito,…
Recognition & Excellence Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors Four specialists at Hawaii Pacific Neuroscience — along with the center itself — have earned a place among the nation’s most recognized physicians and practices, with Castle…
Hawaii Medical Association 2026 Physician of the Year Kore Kai Liow, MD · Hawaiʻi Pacific Neuroscience We are proud to congratulate Dr. Kore Kai Liow, MD, founder of Hawaiʻi Pacific Neuroscience, on being named the 2026 Physician of the Year…
Alzheimer’s Research · Hawaii Memory & Alzheimer’s Research Unit · Published in Nature 2026 University of Hawaii Professor & Researcher Publishes Buntanetap Study in Nature — A Novel Oral Therapy Targeting APP and Tau in Alzheimer’s Disease npj Dementia, Nature…
Epilepsy Research · Hawaii Pacific Neuroscience · Published 2026 Epilepsy Research, Volume 225, 2026 · Hawaii Pacific Neuroscience A new study published in Epilepsy Research by researchers at Hawaii Pacific Neuroscience reveals that Native Hawaiian and Pacific Islander (NHPI) patients…
Epilepsy Research · Hawaii Comprehensive Epilepsy Center Hawaii Awarded Study to Investigate Novel Anti-Galectin-3 Monoclonal Antibody for Drug-Resistant Epilepsy Honolulu, Hawaii · May 2026 · Hawaii Epilepsy Research Unit Dr. Darren Dugas, MD — Neurologist & Epilepsy Specialist, featured on…
RECENT BLOGS
-
Dr. Natalia Gonzalez Caldito Named Chief of Staff at Hawaiʻi Pacific Neuroscience
-
Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors
-
Dr. Kore Kai Liow Named 2026 Hawaii Physician of the Year | HPN
-
University of Hawaii Professor & Researcher Publishes Buntanetap Study in Nature — A Novel Oral Therapy Targeting APP and Tau in Alzheimer’s Disease
-
A Triple Burden In Native Hawaiian And Pacific Islander Patients With Epilepsy: The Cardiometabolic Risks Of Obesity, Diabetes, Smoking, And Their Association With Seizure Control
-
2026 Hawaii Comprehensive Epilepsy Ctr & Epilepsy Research Unit in Hawaii Awarded Study to Investigate Novel anti-Galectin-3 monoclonal Antibody for the Drug-Resistant Epilepsy (DRE)
-
Hawaii Selected to Investigate Povetacicept for Myasthenia Gravis
-
Assessing the Understanding of Neurological Conditions in Young Adults and Leveraging Media Outlets and Social Media Platforms for Neurology Awareness
HPN Office Hours
Monday :
8AM - 5PM
Tuesday :
8AM - 5PM
Wednesday :
8AM - 5PM
Thursday :
8AM - 5PM
Friday :
8AM - 5PM
Saturday :
CLOSED
SUNDAY :
CLOSED